Kalaris Therapeutics, Inc. (KLRS) — Strategic Asset Allocation Index
Kalaris Therapeutics, Inc. (KLRS) has a Strategic Asset Allocation Index of 11.2% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $7.65 Million) total $7.65 Million, measured against net assets of $68.56 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Kalaris Therapeutics, Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Kalaris Therapeutics, Inc. (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Kalaris Therapeutics, Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Kalaris Therapeutics, Inc. market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|